
		March 31, 2022	December 31, 2021		June 30, 2022	December 31, 2021

ASSETS	ASSETS			ASSETS
Current Assets:	Current Assets:			Current Assets:
Cash and cash equivalents	Cash and cash equivalents	$59,266	$61,930	Cash and cash equivalents	$51,546	$61,930
Accounts receivable, net of allowance for doubtful accounts of $1,640 and $2,143, respectively		55,754	53,538
Accounts receivable, net of allowance for doubtful accounts of $1,540 and $2,143, respectively				Accounts receivable, net of allowance for doubtful accounts of $1,540 and $2,143, respectively	38,697	53,538
Inventories	Inventories	22,357	19,780	Inventories	26,944	19,780
Other current assets	Other current assets	23,549	19,878	Other current assets	22,918	19,878
Total Current Assets	Total Current Assets	160,926	155,126	Total Current Assets	140,105	155,126
Property and equipment, net	Property and equipment, net	11,699	11,986	Property and equipment, net	11,385	11,986

Intangible assets, net	Intangible assets, net	535,970	546,652	Intangible assets, net	525,186	546,652
Deferred income tax assets	Deferred income tax assets	7,402	7,392	Deferred income tax assets	8,185	7,392
Other assets	Other assets	12,892	11,406	Other assets	12,020	11,406
TOTAL ASSETS	TOTAL ASSETS	$728,889	$732,562	TOTAL ASSETS	$696,881	$732,562

LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY	LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY			LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY
Current Liabilities:	Current Liabilities:			Current Liabilities:
Accounts payable	Accounts payable	$17,124	$16,969	Accounts payable	$16,745	$16,969
Current portion of long-term debt	Current portion of long-term debt	3,378	3,362	Current portion of long-term debt	3,278	3,362
Income taxes payable	Income taxes payable	2,297	2,382	Income taxes payable	2,147	2,382
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	27,277	26,994	Accrued expenses and other current liabilities	23,054	26,994
Total Current Liabilities	Total Current Liabilities	50,076	49,707	Total Current Liabilities	45,224	49,707
Long-term debt	Long-term debt	253,807	254,194	Long-term debt	253,516	254,194
Other noncurrent liabilities	Other noncurrent liabilities	8,118	6,256	Other noncurrent liabilities	7,553	6,256
Deferred income tax liabilities	Deferred income tax liabilities	33,663	34,833	Deferred income tax liabilities	31,079	34,833
Total Liabilities	Total Liabilities	345,664	344,990	Total Liabilities	337,372	344,990

Commitments and contingencies (see Note 20)	Commitments and contingencies (see Note 20)	0	0	Commitments and contingencies (see Note 20)	0	0
Temporary Equity:	Temporary Equity:			Temporary Equity:
Series B convertible preferred stock, par value $0.0001; 150 shares authorized and designated and 145 shares outstanding at March 31, 2022 and December 31, 2021, respectively		151,800	149,386
Series B convertible preferred stock, par value $0.0001; 150 shares authorized and designated and 145 shares outstanding at June 30, 2022 and December 31, 2021, respectively				Series B convertible preferred stock, par value $0.0001; 150 shares authorized and designated and 145 shares outstanding at June 30, 2022 and December 31, 2021, respectively	155,066	149,386
Redeemable non-controlling interest	Redeemable non-controlling interest	7,705	7,787	Redeemable non-controlling interest	7,353	7,787
Stockholders’ Equity:	Stockholders’ Equity:			Stockholders’ Equity:
Common stock, par value $0.0001; 400,000 shares authorized, 53,244 and 53,080 shares issued and 52,583 and 52,418 outstanding at March 31, 2022 and December 31, 2021, respectively		5	5
Preferred stock, par value $0.0001; 0.001 share authorized and outstanding at March 31, 2022 and December 31, 2021		—	—
Treasury stock, par value $0.0001; 661 shares at March 31, 2022 and December 31, 2021		(3,885)	(3,885)
Common stock, par value $0.0001; 400,000 shares authorized, 53,354 and 53,080 shares issued and 52,693 and 52,418 outstanding at June 30, 2022 and December 31, 2021, respectively				Common stock, par value $0.0001; 400,000 shares authorized, 53,354 and 53,080 shares issued and 52,693 and 52,418 outstanding at June 30, 2022 and December 31, 2021, respectively	5	5
Preferred stock, par value $0.0001; 0.001 share authorized and outstanding at June 30, 2022 and December 31, 2021				Preferred stock, par value $0.0001; 0.001 share authorized and outstanding at June 30, 2022 and December 31, 2021	—	—
Treasury stock, par value $0.0001; 661 shares at June 30, 2022 and December 31, 2021				Treasury stock, par value $0.0001; 661 shares at June 30, 2022 and December 31, 2021	(3,885)	(3,885)
Additional paid-in capital	Additional paid-in capital	523,544	529,303	Additional paid-in capital	518,322	529,303
Accumulated deficit	Accumulated deficit	(251,747)	(248,660)	Accumulated deficit	(269,763)	(248,660)
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(44,197)	(46,364)	Accumulated other comprehensive loss	(47,589)	(46,364)
Total Stockholders' Equity	Total Stockholders' Equity	223,720	230,399	Total Stockholders' Equity	197,090	230,399
TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY	TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY	$728,889	$732,562	TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY	$696,881	$732,562


		Three Months Ended March 31,		Three Months Ended June 30,				Six Months Ended June 30,
		2022	2021			2022	2021		2022	2021
Net sales	Net sales	$39,889	$38,992		Net sales	$25,752	$21,924		$65,641	$60,916
Cost of sales (excluding amortization, shown separately below)	Cost of sales (excluding amortization, shown separately below)	11,923	10,314		Cost of sales (excluding amortization, shown separately below)	9,292	7,104		21,215	17,418
Gross profit	Gross profit	27,966	28,678		Gross profit	16,460	14,820		44,426	43,498
Research and development expenses	Research and development expenses	3,051	3,298		Research and development expenses	2,884	3,496		5,935	6,794
Selling, general and administrative expenses	Selling, general and administrative expenses	11,892	13,551		Selling, general and administrative expenses	14,334	13,620		26,226	27,171
Amortization of intangibles	Amortization of intangibles	10,718	10,763		Amortization of intangibles	10,708	10,499		21,426	21,262

Operating income		2,305	1,066
Other income		505	14,398

Operating loss					Operating loss	(11,466)	(12,795)		(9,161)	(11,729)
Other income (expense)					Other income (expense)	9	(46)		514	14,352
(Loss) gain on foreign currency exchange	(Loss) gain on foreign currency exchange	(1,196)	433		(Loss) gain on foreign currency exchange	(4,878)	921		(6,074)	1,354
Interest expense, net	Interest expense, net	(4,947)	(5,890)		Interest expense, net	(5,092)	(5,216)		(10,039)	(11,106)
(Loss) income before income taxes		(3,333)	10,007
Loss before income taxes					Loss before income taxes	(21,427)	(17,136)		(24,760)	(7,129)
Income taxes (benefit) expense	Income taxes (benefit) expense	(164)	1,823		Income taxes (benefit) expense	(3,058)	144		(3,222)	1,967
Net (loss) income including non-controlling interest		(3,169)	8,184
Net loss including non-controlling interest					Net loss including non-controlling interest	(18,369)	(17,280)		(21,538)	(9,096)
Less: Net loss attributable to non-controlling interests	Less: Net loss attributable to non-controlling interests	(82)	(239)		Less: Net loss attributable to non-controlling interests	(353)	(20)		(435)	(259)
Net (loss) income attributable to AgroFresh Solutions, Inc.		(3,087)	8,423
Net loss attributable to AgroFresh Solutions, Inc.					Net loss attributable to AgroFresh Solutions, Inc.	(18,016)	(17,260)		(21,103)	(8,837)
Less: Dividends on convertible preferred stock	Less: Dividends on convertible preferred stock	6,436	6,005		Less: Dividends on convertible preferred stock	6,533	6,327		12,969	12,332
Net (loss) income attributable to AgroFresh Solutions, Inc. common stockholders		($9,523)	$2,418
Net loss attributable to AgroFresh Solutions, Inc. common stockholders					Net loss attributable to AgroFresh Solutions, Inc. common stockholders	($24,549)	($23,587)		($34,072)	($21,169)

(Loss) earnings per share of common shares:
Loss per share of common shares:					Loss per share of common shares:
Basic	Basic	($0.18)	$0.03		Basic	($0.47)	($0.46)		($0.66)	($0.41)
Diluted	Diluted	($0.18)	$0.03		Diluted	($0.47)	($0.46)		($0.66)	($0.41)

Weighted average shares of common stock outstanding:	Weighted average shares of common stock outstanding:				Weighted average shares of common stock outstanding:
Basic	Basic	51,736	51,031		Basic	52,089	51,348		51,913	51,191
Diluted	Diluted	51,736	52,296		Diluted	52,089	51,348		51,913	51,191


		Three Months Ended March 31,		Three Months Ended June 30,				Six Months Ended June 30,
		2022	2021			2022	2021		2022	2021
Net (loss) income		($3,169)	$8,184
Net loss					Net loss	($18,369)	($17,280)		($21,538)	($9,096)
Other comprehensive (loss) income:	Other comprehensive (loss) income:				Other comprehensive (loss) income:
Foreign currency translation adjustments	Foreign currency translation adjustments	2,167	(6,558)		Foreign currency translation adjustments	(3,392)	401		(1,225)	(6,157)

Comprehensive (loss) income, net of tax		($1,002)	$1,626
Comprehensive loss, net of tax					Comprehensive loss, net of tax	($21,761)	($16,879)		($22,763)	($15,253)


		Preferred Stock		Common Stock		Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total Stockholders’ Equity		Preferred Stock		Common Stock		Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total Stockholders’ Equity
		Shares	Amount	Shares	Amount							Shares	Amount	Shares	Amount
Balances, December 31, 2021	Balances, December 31, 2021	—	$—	53,080	$5	($3,885)	$529,303	($248,660)	($46,364)	$230,399	Balances, December 31, 2021	—	$—	53,080	$5	($3,885)	$529,303	($248,660)	($46,364)	$230,399
Stock-based compensation	Stock-based compensation	—	—	—	—	—	902	—		902	Stock-based compensation	—	—	—	—	—	2,242	—		2,242
Issuance of stock, net of forfeitures	Issuance of stock, net of forfeitures	—	—	182	—	—	—				Issuance of stock, net of forfeitures	—	—	390	—	—	—
Shares withheld for taxes	Shares withheld for taxes	—	—	(18)	—	—	(225)	—		(225)	Shares withheld for taxes	—	—	(116)	—	—	(400)	—		(400)

Issuance of common stock under employee stock purchase plan											Issuance of common stock under employee stock purchase plan	—	—	—	—	—	146	—		146
Convertible preferred dividend	Convertible preferred dividend	—	—	—	—	—	(6,436)	—		(6,436)	Convertible preferred dividend	—	—	—	—	—	(12,969)	—		(12,969)

Net loss attributable to AgroFresh Solutions, Inc.	Net loss attributable to AgroFresh Solutions, Inc.	—	—	—	—	—	—	(3,087)	—	(3,087)	Net loss attributable to AgroFresh Solutions, Inc.	—	—	—	—	—	—	(21,103)	—	(21,103)
Comprehensive income		—	—	—	—	—	—		2,167
Balances, March 31, 2022		—	$—	53,244	$5	($3,885)	$523,544	($251,747)	($44,197)	$223,720
Comprehensive loss											Comprehensive loss	—	—	—	—	—	—		(1,225)
Balances, June 30, 2022											Balances, June 30, 2022	—	$—	53,354	$5	($3,885)	$518,322	($269,763)	($47,589)	$197,090


	Preferred Stock		Common Stock		Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total Stockholders’ Equity
	Shares	Amount	Shares	Amount	Amount
Balance at March 31, 2022	—	$—	53,244	$5	($3,885)	$523,544	($251,747)	($44,197)	$223,720
Stock-based compensation	—	—	—	—	—	1,340	—	—	1,340
Issuance of stock, net of forfeitures	—	—	208	—	—	—	—	—	—
Shares withheld for taxes	—	—	(98)	—	—	(175)	—	—	(175)
Issuance of common stock under employee stock purchase plan	—	—	—	—	—	146	—	—	146
Convertible preferred dividend and accretion	—	—	—	—	—	(6,533)	—	—	(6,533)

Net loss attributable to AgroFresh Solutions, Inc.	—	—	—	—	—	—	(18,016)	—	(18,016)
Comprehensive loss	—	—	—	—	—	—	—	(3,392)	(3,392)
Balance at June 30, 2022	—	$—	53,354	$5	($3,885)	$518,322	($269,763)	($47,589)	$197,090

Preferred Stock Common Stock Treasury Stock Additional Paid-in Capital Accumulated
Deficit Accumulated
Other
Comprehensive
Loss Total
Stockholders’
Equity
Shares Amount Shares Amount Amount
Balances, December 31, 2020 — $— 53,092 $5 ($3,885) $552,776 ($244,836) ($31,667) $272,393
Stock-based compensation — — — — — 752 — — 752
Issuance of stock, net of forfeitures — — (20) — — — — — —
Shares withheld for taxes — — (21) — — (43) — — (43)
Convertible preferred dividend — — — — — (6,005) — — (6,005)
Net loss attributable to AgroFresh Solutions, Inc. — — — — — — 8,423 — 8,423
Comprehensive loss — — — — — — — (6,558) (6,558)
Balances, March 31, 2021 — $— 53,051 $5 ($3,885) $547,480 ($236,413) ($38,225) $268,962


	Preferred Stock		Common Stock		Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total Stockholders’ Equity
	Shares	Amount	Shares	Amount	Amount
Balances, December 31, 2020	—	$—	53,092	$5	($3,885)	$552,776	($244,836)	($31,667)	$272,393
Stock-based compensation	—	—	—	—	—	1,082	—	—	1,082
Issuance of stock, net of forfeitures	—	—	(258)	—	—	—	—	—	—
Shares withheld for taxes	—	—	(120)	—	—	(266)	—	—	(266)
Issuance of common stock under employee stock purchase plan	—	—	92	—	—	163	—	—	163
Convertible preferred dividend	—	—	—	—	—	(12,332)	—	—	(12,332)
Adjustment of NCI to redemption value	—	—	—	—	—	(238)	238	—	—
Net loss attributable to AgroFresh Solutions, Inc.	—	—	—	—	—	—	(8,837)	—	(8,837)
Comprehensive loss	—	—	—	—	—	—	—	(6,157)	(6,157)
Balances, June 30, 2021	—	$—	52,806	$5	($3,885)	$541,185	($253,435)	($37,824)	$246,046


	Preferred Stock		Common Stock		Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total Stockholders’ Equity
	Shares	Amount	Shares	Amount	Amount
Balances, March 31, 2021	—	$—	53,051	$5	($3,885)	$547,480	($236,413)	($38,225)	$268,962
Stock-based compensation	—	—	—	—	—	330	—	—	330
Issuance of stock, net of forfeitures	—	—	(237)	—	—	—	—	—	—
Shares withheld for taxes	—	—	(100)	—		(223)	—	—	(223)
Issuance of common stock under employee stock purchase plan	—	—	92	—	—	163	—	—	163
Convertible preferred dividend	—	—	—	—	—	(6,327)	—	—	(6,327)
Adjustment of NCI to redemption value	—	—	—	—	—	(238)	238	—	—
Net loss attributable to AgroFresh Solutions, Inc.	—	—	—	—	—	—	(17,260)	—	(17,260)
Comprehensive income	—	—	—	—	—	—	—	401	401
Balances, June 30, 2021	—	$—	52,806	$5	($3,885)	$541,185	($253,435)	($37,824)	$246,046

Three Months Ended March 31,
(in thousands) 2022 2021
Cash flows from operating activities:
Net (loss) income ($3,169) $8,184
Adjustments to reconcile net (loss) income to net cash provided in operating activities:
Depreciation and amortization 11,444 11,423
Stock-based compensation 902 752
Amortization of deferred financing costs 511 774
Deferred income taxes (981) 937
Provision for bad debts 138 396
Loss on sales of property and equipment 5 7
Changes in operating assets and liabilities:
Accounts receivable (321) 5,576
Inventories (2,312) 1,256
Prepaid expenses and other current assets (3,401) (1,645)
Accounts payable 14 (2,584)
Accrued expenses and other liabilities (292) (607)
Income taxes payable (214) 447
Other assets and liabilities 163 (1,590)
Net cash provided by operating activities 2,487 23,326
Cash flows from investing activities:
Capital expenditures (596) (430)
Net cash used in investing activities (596) (430)
Cash flows from financing activities:
Repayment of long-term debt (823) (9,904)
Payment of preferred dividends (4,023) (3,002)
Payment for redemption of convertible preferred stock — (5,330)
Net cash used in financing activities (4,846) (18,236)
Effect of exchange rate changes on cash and cash equivalents 291 (1,822)
Net (decrease) increase in cash and cash equivalents (2,664) 2,838
Cash and cash equivalents, beginning of period 61,930 50,030
Cash and cash equivalents, end of period $59,266 $52,868
Supplemental disclosures of cash flow information:
Cash paid for:
Cash paid for interest $4,788 $5,012
Cash paid for income taxes $1,945 $842
Supplemental schedule of non-cash investing and financing activities:
Accrued purchases of property and equipment $96 $95


	Six Months Ended June 30,
(in thousands)	2022	2021
Cash flows from operating activities:
Net loss	($21,538)	($9,096)
Adjustments to reconcile net loss to net cash provided in operating activities:
Depreciation and amortization	22,892	22,600
Stock-based compensation	2,242	1,082
Amortization of deferred financing costs	1,037	1,266
Deferred income taxes	(3,712)	2,042
Provision for bad debts	133	190
(Gain) loss on sales of property and equipment	(5)	56
Changes in operating assets and liabilities:
Accounts receivable	18,973	27,078
Inventories	(8,310)	(506)
Prepaid expenses and other current assets	(5,000)	(3,804)
Accounts payable	425	(6,243)
Accrued expenses and other liabilities	(2,662)	(3,848)
Income taxes payable	(177)	240
Other assets and liabilities	23	(181)
Net cash provided by operating activities	4,321	30,876
Cash flows from investing activities:
Capital expenditures	(1,672)	(1,304)
Net cash used in investing activities	(1,672)	(1,304)
Cash flows from financing activities:
Repayment of long-term debt	(1,631)	(10,729)
Payment of preferred dividends	(7,289)	(6,065)
Payment for redemption of convertible preferred stock	—	(5,330)
Proceeds from issuance of stock under employee stock purchase plan	146	163
Net cash used in financing activities	(8,774)	(21,961)
Effect of exchange rate changes on cash and cash equivalents	(4,259)	(947)
Net (decrease) increase in cash and cash equivalents	(10,384)	6,664
Cash and cash equivalents, beginning of period	61,930	50,030
Cash and cash equivalents, end of period	$51,546	$56,694

Supplemental disclosures of cash flow information:
Cash paid for:
Cash paid for interest	$9,628	$9,899
Cash paid for income taxes	$2,882	$2,196
Supplemental schedule of non-cash investing and financing activities:
Accrued purchases of property and equipment	$364	$105

AgroFresh Solutions, Inc. (the “Company”) is an agriculture technology innovator and global leader with a mission to prevent food loss and waste and conserve the planet’s resources by providing a range of science-based solutions, data-driven digital technologies and high-touch customer services. The Company supports growers, packers and retailers with solutions across the food supply chain to enhance the quality and extend the shelf life of fresh produce. The Company has 40 years of post-harvest experience across a broad range of crops, including revolutionizing the apple industry with the SmartFresh™ Quality System more than 20 years ago. The AgroFresh platform is powered by the Company's comprehensive portfolio that includes plant-based coatings, equipment and proprietary solutions that help improve the freshness supply chain from harvest to the home.

The Company has an extensive portfolio of solutions to extend freshness across the produce supply chain from near-harvest up to the point-of sale. These include Harvista™ for near-harvest optimization, and the SmartFresh™ Quality System, the Company's flagship post-harvest freshness solutions. Additional post-harvest freshness solutions include fungicides that can be applied to meet various customer operational requirements in both foggable (ActiMist™) and liquid (ActiSeal™) delivery options. The Company has a controlling interest in AgroFresh Fruit Protection S.A. ("AgroFresh Fruit Protection") (formerly Tecnidex Fruit Protection, S.A.), a leading regional provider of post-harvest fungicides, disinfectants, coatings and packinghouse equipment for the citrus market. Beyond apples and pears, SmartFresh technology can provide ready-to-eat freshness for other fruits and vegetables including avocados, bananas, melons, tomatoes, broccoli and mangos. The Company has key products registered in approximately 50 countries, and supports customers by protecting over 25,000 storage rooms globally.

The end-markets that the Company serves are seasonal and are generally aligned with the seasonal growing patterns of the Company’s customers. For those customers growing, harvesting or storing apples and pears, the Company’s core crops, the peak season in the southern hemisphere is the first and second quarters of each year, while the peak season in the northern hemisphere is the third and fourth quarters of each year. Within each half-year period (i.e., January through June for the southern hemisphere, and July through December for the northern hemisphere) the growing season has historically occurred during both quarters. A variety of factors, including weather, may affect the timing of the growing, harvesting and storing patterns of the Company’s customers and therefore shift the consumption of the Company’s services and products between the first and second quarters primarily in the southern hemisphere or between the third and fourth quarters primarily in the northern hemisphere.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. For additional information, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2021. Certain prior period amounts have been reclassified to conform to the current year presentation.

The global health crisis caused by COVID-19 and the related government actions and stay at home orders have negatively impacted economic activity and increased political instability across the globe. The outbreak could have a continued material adverse impact on economic and market conditions and trigger a period of global economic slowdown. There have been numerous obstacles presented and some localized financial impacts of the pandemic, including fluctuations in foreign currency exchange rates and customer demand and spending pattern changes. During the ~~three~~six months ended ~~March 31,~~June 30, 2022, the COVID-19 pandemic did not have a significant adverse impact on the Company’s results of operations. While the Company is following the requirements of governmental authorities and taking additional preventative and protective measures to ensure the safety of its workforce, including remote working arrangements and varying procedures for essential workforce, the outbreak presents some uncertainty and risk with respect to the Company and its performance and financial results.

~~sources for~~ measuring and reporting ~~inflation.~~inflation in applicable countries. In the second quarter of 2018, the Argentine peso rapidly devalued relative to the U.S. dollar, which along with increased inflation, indicated that the three-year cumulative inflation rate in that country exceeded 100 percent as of June 30, 2018. As a result, the Company elected to adopt highly inflationary accounting as of July 1, 2018 for its subsidiary in Argentina. As the three-year cumulative inflation rate exceeded 100 percent as of June 30, 2022, there is no change to highly inflationary accounting in Argentina.

Under highly inflationary accounting, the functional ~~currency~~currencies of the Company's ~~subsidiary~~subsidiaries in Argentina and Turkey became the U.S. dollar, and its income statement and balance sheet will be measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates in the currencies of these countries on ~~Argentine peso-denominated~~ monetary assets and liabilities are reflected in earnings. As ~~the three-year cumulative inflation rate exceeded 100 percent as~~ of ~~March 31, 2022, there is no change to highly inflationary accounting. As of March 31,~~June 30, 2022, the Company’s subsidiary in Argentina had net assets of ($~~8.7)~~9.9) million. Net sales attributable to Argentina were approximately ~~10.5%~~8% and ~~11%~~8% of the Company’s consolidated net sales for the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, respectively. As of June 30, 2022, the Company’s subsidiary in Turkey had net assets of $10.9 million. Net sales attributable to Turkey were approximately 1% of the Company’s consolidated net sales for the six months ended June 30, 2022.

Revenues for the three months ended ~~March 31,~~June 30, 2022


(in thousands)	(in thousands)						(in thousands)
Region	Region	North America (1)	EMEA (2)	Latin America (3)	Asia Pacific (4)	Total Revenues	Region	North America (1)	EMEA (2)	Latin America (3)	Asia Pacific (4)	Total Revenues
Product	Product						Product
1-MCP based	1-MCP based	$1,531	$6,567	$16,539	$6,114	$30,751	1-MCP based	$1,604	$5,238	$6,501	$5,808	$19,151
Fungicides, disinfectants and coatings	Fungicides, disinfectants and coatings	—	5,853	2,120	—	7,973	Fungicides, disinfectants and coatings	—	4,505	1,704	93	6,302
Other*	Other*	314	398	384	69	1,165	Other*	2	—	99	198	299
		$1,845	$12,818	$19,043	$6,183	$39,889		$1,606	$9,743	$8,304	$6,099	$25,752

Pattern of Revenue Recognition	Pattern of Revenue Recognition						Pattern of Revenue Recognition
Products transferred at a point in time	Products transferred at a point in time	$1,656	$12,431	$18,935	$6,140	$39,162	Products transferred at a point in time	$1,542	$9,588	$8,069	$6,021	$25,220
Services transferred over time	Services transferred over time	189	387	108	43	727	Services transferred over time	64	155	235	78	532
		$1,845	$12,818	$19,043	$6,183	$39,889		$1,606	$9,743	$8,304	$6,099	$25,752

Revenues for the three months ended ~~March 31,~~June 30, 2021


(in thousands)	(in thousands)						(in thousands)
Region	Region	North America (1)	EMEA (2)	Latin America (3)	Asia Pacific (4)	Total Revenues	Region	North America (1)	EMEA (2)	Latin America (3)	Asia Pacific (4)	Total Revenues
Product	Product						Product
1-MCP based	1-MCP based	$1,764	$5,362	$18,741	$5,963	$31,830	1-MCP based	$580	$5,434	$5,623	$5,212	$16,849
Fungicides, disinfectants and coatings	Fungicides, disinfectants and coatings	14	4,546	1,547	—	6,107	Fungicides, disinfectants and coatings	—	3,317	999	—	4,316
Other*	Other*	156	400	451	48	1,055	Other*	235	74	350	100	759
		$1,934	$10,308	$20,739	$6,011	$38,992		$815	$8,825	$6,972	$5,312	$21,924

Pattern of Revenue Recognition	Pattern of Revenue Recognition						Pattern of Revenue Recognition
Products transferred at a point in time	Products transferred at a point in time	$1,767	$9,908	$20,627	$5,972	$38,274	Products transferred at a point in time	$588	$8,755	$6,725	$5,218	$21,286
Services transferred over time	Services transferred over time	167	400	112	39	718	Services transferred over time	227	70	247	94	638
		$1,934	$10,308	$20,739	$6,011	$38,992		$815	$8,825	$6,972	$5,312	$21,924


(in thousands)
Region	North America (1)	EMEA (2)	Latin America (3)	Asia Pacific (4)	Total Revenues
Product
1-MCP based	$3,135	$11,805	$23,040	$11,922	$49,902
Fungicides, disinfectants and coatings	—	10,358	3,824	93	14,275
Other*	316	398	483	267	1,464
	$3,451	$22,561	$27,347	$12,282	$65,641

Pattern of Revenue Recognition
Products transferred at a point in time	$3,198	$22,021	$27,004	$12,161	$64,384
Services transferred over time	253	540	343	121	1,257
	$3,451	$22,561	$27,347	$12,282	$65,641


(in thousands)
Region	North America (1)	EMEA (2)	Latin America (3)	Asia Pacific (4)	Total Revenues
Product
1-MCP based	$2,344	$10,796	$24,364	$11,176	$48,680
Fungicides, disinfectants and coatings	14	7,863	2,546	—	10,423
Other*	391	473	801	148	1,813
	$2,749	$19,132	$27,711	$11,324	$60,916

Pattern of Revenue Recognition
Products transferred at a point in time	$2,355	$18,663	$27,352	$11,191	$59,561
Services transferred over time	394	469	359	133	1,355
	$2,749	$19,132	$27,711	$11,324	$60,916

Accounting Standards Codification ("ASC") 606 Revenue from contracts with Customers requires an entity to present a revenue contract as a contract asset when the entity performs its obligations under the contract by transferring goods or services to a customer before the customer pays consideration or before payment is due. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g., receivable), before the entity transfers a good or service to the customer. The following table presents changes in the Company’s contract assets and liabilities during the ~~three~~six months ended ~~March 31,~~June 30, 2022 and the year ended December 31, 2021:


(in thousands)	(in thousands)	Balance at December 31, 2021	Additions	Deductions	Balance at March 31, 2022	(in thousands)	Balance at December 31, 2021	Additions	Deductions	Balance at June 30, 2022
Contract assets:	Contract assets:					Contract assets:
Unbilled revenue	Unbilled revenue	$795	4,244	(2,587)	$2,452	Unbilled revenue	$795	7,030	(5,599)	$2,226
Contract liabilities:	Contract liabilities:					Contract liabilities:
Deferred revenue	Deferred revenue	$635	1,766	(702)	$1,699	Deferred revenue	$635	2,078	(2,279)	$434

The Company recognizes contract assets in the form of unbilled revenue in instances where services are performed by the Company but not billed by period end. The Company recognizes contract liabilities in the form of deferred revenue in instances where a customer pays in advance for future services to be performed by the Company. The Company generally receives payments from its customers based on standard terms and conditions. No significant changes or impairment losses occurred to contract balances during the ~~three~~six months ended ~~March 31,~~June 30, 2022. Amounts reclassified from unbilled revenue to accounts receivable for the ~~three~~six months ended ~~March 31,~~June 30, 2022 and for the year ended December 31, 2021 were ~~$2.6~~$5.6 million and $18.3 million, respectively. Amounts reclassified from deferred revenue to revenue for the ~~three~~six months ended ~~March 31,~~June 30, 2022 and for the year ended December 31, 2021 were ~~$0.7~~$2.3 million and $5.0 million, respectively.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments simplify the accounting for income taxes by removing certain exceptions to the general principles of Topic 740, "Income Taxes" and also improve consistent application by clarifying and amending existing guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted the new guidance on January 1, 2021. The adoption of the new guidance did not have a material impact on the condensed consolidated financial statements of the Company.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments are intended to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. The new standard is effective on a date selected by the Company between March 12, 2020 and December 31, 2022. The Company is currently evaluating the impact of adopting this guidance.

On June 13, 2020, in connection with the execution of the Investment Agreement (as defined in Note 15 - Series B Convertible Preferred Stock and Stockholders’ Equity), the Company, PSP AGFS Holdings, L.P. (“PSP”) and Rohm and Haas Company ("R&H") entered into a side agreement, pursuant to which the parties agreed that if PSP or its affiliates has the right to designate at least 50% of the total directors on the Company’s board of directors pursuant to the Investment Agreement, so long as R&H or its affiliates beneficially owns at least 20% of the Company’s outstanding common stock (on a fully diluted, “as converted” basis), the Company and the board of directors will increase the size of the board of directors by 1 member and the board will elect a designee selected by R&H to fill the newly-created vacancy. Such right is in addition to any right that R&H has to appoint a member of the board pursuant to its ownership of the Company’s Series A preferred stock (see Note 15 - Series B Convertible Preferred Stock and Stockholders’ Equity).

During 2016, the Company made a minority investment in RipeLocker, LLC ("RipeLocker"), a company led by George Lobisser who was formerly a director of the Company. In February 2019, the Company made a further minority investment in RipeLocker. As of and for the ~~three~~six months ended ~~March 31,~~June 30, 2022, there were no material amounts paid or owed to RipeLocker or Mr. Lobisser. Mr. Lobisser resigned as a director of the Company on February 18, 2021.

Inventories at ~~March 31,~~June 30, 2022 and December 31, 2021 consisted of the following:


(in thousands)	(in thousands)	March 31, 2022	December 31, 2021	(in thousands)	June 30, 2022	December 31, 2021
Raw material	Raw material	$3,237	$2,726	Raw material	$3,084	$2,726
Work-in-process	Work-in-process	4,956	3,746	Work-in-process	4,460	3,746
Finished goods	Finished goods	13,219	12,520	Finished goods	18,355	12,520
Supplies	Supplies	945	788	Supplies	1,045	788
Total inventories	Total inventories	$22,357	$19,780	Total inventories	$26,944	$19,780

The Company's other current assets at ~~March 31,~~June 30, 2022 and December 31, 2021 consisted of the following:


(in thousands)	(in thousands)	March 31, 2022	December 31, 2021	(in thousands)	June 30, 2022	December 31, 2021
VAT receivable	VAT receivable	$12,371	$10,220	VAT receivable	$11,432	$10,220
Income tax receivable		7,461	6,256
Prepaid income tax asset				Prepaid income tax asset	7,540	6,256
Prepaid and other current assets	Prepaid and other current assets	3,717	3,402	Prepaid and other current assets	3,946	3,402
Total other current assets	Total other current assets	$23,549	$19,878	Total other current assets	$22,918	$19,878

Property and equipment at ~~March 31,~~June 30, 2022 and December 31, 2021 consisted of the following:


(in thousands, except for useful life data)	(in thousands, except for useful life data)	Useful life (years)	March 31, 2022	December 31, 2021	(in thousands, except for useful life data)	Useful life (years)	June 30, 2022	December 31, 2021
Buildings and leasehold improvements	Buildings and leasehold improvements	7-20	$7,275	$6,967	Buildings and leasehold improvements	7-20	$7,053	$6,967
Machinery & equipment	Machinery & equipment	1-12	13,805	13,158	Machinery & equipment	1-12	13,747	13,158
Furniture	Furniture	1-12	2,942	2,927	Furniture	1-12	2,886	2,927
Construction in progress	Construction in progress		1,196	1,780	Construction in progress		1,558	1,780
			25,218	24,832			25,244	24,832
Less: accumulated depreciation	Less: accumulated depreciation		(13,519)	(12,846)	Less: accumulated depreciation		(13,859)	(12,846)
Total property and equipment, net	Total property and equipment, net		$11,699	$11,986	Total property and equipment, net		$11,385	$11,986

As a result of the operating segment realignment discussed in Note 19 - Segment Information, the composition of the Company's reporting units for the evaluation of goodwill impairment has changed. Historically, the Company's reporting units were identified at the operating segment level, which consisted of AgroFresh Core and AgroFresh Fruit Protection and all of the Company's goodwill was assigned to the AgroFresh Fruit Protection reporting unit. Effective December 31, 2021, the Company concluded that it has 1 operating segment and 1 reporting unit, which resulted in the reassignment of its goodwill to its stand-alone reporting unit. Prior to the change, the Company tested goodwill for impairment at the previous reporting unit, which did not result in any impairment charge. Based upon the Company's impairment assessment at the new reporting unit (consolidated AgroFresh), the Company determined the carrying amount of the consolidated entity exceeded its fair value. As a result, the Company recorded $6.4 million in goodwill impairment charges during the year ended December 31, 2021.


		March 31, 2022			December 31, 2021			June 30, 2022					December 31, 2021
(in thousands)	(in thousands)	Gross Carrying Amount	Accumulated Amortization	Net		Gross Carrying Amount	Accumulated Amortization		Net	(in thousands)	Gross Carrying Amount	Accumulated Amortization		Net	Gross Carrying Amount	Accumulated Amortization	Net
Intangible assets with finite lives:	Intangible assets with finite lives:									Intangible assets with finite lives:
Developed technology	Developed technology	$798,640	($303,707)	$494,933		$798,669	($293,920)		$504,749	Developed technology	$798,490	($313,437)		$485,053	$798,669	($293,920)	$504,749
Customer relationships	Customer relationships	19,583	(7,242)	12,341		19,778	(6,948)		12,830	Customer relationships	18,911	(7,306)		11,605	19,778	(6,948)	12,830
Software	Software	11,175	(10,386)	789		10,992	(10,235)		757	Software	11,435	(10,328)		1,107	10,992	(10,235)	757
Trade name	Trade name	3,576	(1,073)	2,503		3,635	(727)		2,908	Trade name	3,368	(1,347)		2,021	3,635	(727)	2,908
Other	Other	100	(96)	4		100	(92)		8	Other	100	(100)		—	100	(92)	8
Total intangible assets with finite lives	Total intangible assets with finite lives	833,074	(322,504)	510,570		833,174	(311,922)		521,252	Total intangible assets with finite lives	832,304	(332,518)		499,786	833,174	(311,922)	521,252
Intangible assets with indefinite lives:	Intangible assets with indefinite lives:									Intangible assets with indefinite lives:
Trade name	Trade name	23,400	—	23,400		23,400	—		23,400	Trade name	23,400	—		23,400	23,400	—	23,400
Service provider network	Service provider network	2,000	—	2,000		2,000	—		2,000	Service provider network	2,000	—		2,000	2,000	—	2,000
Total intangible assets with indefinite lives	Total intangible assets with indefinite lives	25,400	—	25,400		25,400	—		25,400	Total intangible assets with indefinite lives	25,400	—		25,400	25,400	—	25,400
Total intangible assets	Total intangible assets	$858,474	($322,504)	$535,970		$858,574	($311,922)		$546,652	Total intangible assets	$857,704	($332,518)		$525,186	$858,574	($311,922)	$546,652


(in thousands)	(in thousands)	March 31, 2022	December 31, 2021	(in thousands)	June 30, 2022	December 31, 2021
Right-of-use asset	Right-of-use asset	$7,831	$6,258	Right-of-use asset	$7,275	$6,258
Long-term sales-type lease receivable	Long-term sales-type lease receivable	2,892	2,860	Long-term sales-type lease receivable	2,654	2,860
Other long-term receivable	Other long-term receivable	2,169	2,288	Other long-term receivable	2,091	2,288
Total other assets	Total other assets	$12,892	$11,406	Total other assets	$12,020	$11,406


(in thousands)	(in thousands)	March 31, 2022	December 31, 2021	(in thousands)	June 30, 2022	December 31, 2021
Accrued taxes	Accrued taxes	$10,491	$8,267	Accrued taxes	$7,663	$8,267
Accrued compensation and benefits	Accrued compensation and benefits	6,622	8,227	Accrued compensation and benefits	6,866	8,227
Bank overdraft	Bank overdraft	2,274	1,612	Bank overdraft	1,771	1,612
Lease liability				Lease liability	1,358	1,624
Severance				Severance	854	1,259
Accrued rebates payable				Accrued rebates payable	647	756
Deferred revenue	Deferred revenue	1,699	635	Deferred revenue	434	635
Lease liability		1,400	1,624
Accrued rebates payable		887	756
Severance		383	1,259
Accrued interest	Accrued interest	74	72	Accrued interest	79	72
Other	Other	3,447	4,542	Other	3,382	4,542
Total accrued and other current liabilities	Total accrued and other current liabilities	$27,277	$26,994	Total accrued and other current liabilities	$23,054	$26,994


(in thousands)	(in thousands)	March 31, 2022	December 31, 2021	(in thousands)	June 30, 2022	December 31, 2021
Total term loan outstanding	Total term loan outstanding	$261,813	$262,501	Total term loan outstanding	$261,125	$262,501
Unamortized deferred issuance costs	Unamortized deferred issuance costs	(5,955)	(6,434)	Unamortized deferred issuance costs	(5,463)	(6,434)
AgroFresh Fruit Protection loan outstanding	AgroFresh Fruit Protection loan outstanding	1,327	1,489	AgroFresh Fruit Protection loan outstanding	1,132	1,489
Less: Amounts due within one year	Less: Amounts due within one year	3,378	3,362	Less: Amounts due within one year	3,278	3,362
Total long-term debt due after one year	Total long-term debt due after one year	$253,807	$254,194	Total long-term debt due after one year	$253,516	$254,194

On July 27, 2020, the Company completed a comprehensive refinancing (the “Refinancing”) by (i) entering into an Amended and Restated Credit Agreement (the “Amended Credit Agreement”) with the other loan parties party thereto, Bank of Montreal, as administrative agent and the lenders party thereto, and (ii) consummating the transactions contemplated by the Investment Agreement (as defined and described in Note 15 – Series B Convertible Preferred Stock and Stockholders’ Equity). The Amended

The Amended Credit Agreement provides for a $25.0 million revolving credit facility (the “Amended Revolving Loan”), which matures on June 30, 2024, and a $275.0 million term credit facility (the “Amended Term Loan” and, together with the Amended Revolving Loan, the “Amended Credit Facility”), which matures on December 31, 2024. The Amended Credit Facility includes a $5.0 million swingline commitment and a $10.0 million letter of credit sub-limit. Loans under the Amended Term Loan bear interest at a rate equal to, at the Company’s option, either the Adjusted Eurodollar Rate for the interest period in effect for such borrowing plus an Applicable Rate of 6.25% per annum, or the Alternate Base Rate plus an Applicable Rate of 5.25% per annum. Loans under the Amended Revolving Loan bear interest at a rate equal to, at the Company’s option, the Adjusted Eurodollar Rate for the interest period in effect for such borrowing plus the Applicable Rate ranging from 6.25% to 6.0% per annum, based on certain ratios. The interest rate was 7.25% for each of the three and six months ended ~~March 31,~~June 30, 2022. The Company is also required to pay a commitment fee on the unused portion of the Amended Revolving Loan at a rate ranging from 0.5% to 0.375%, based on certain ratios. The Company is required to make mandatory prepayments of outstanding indebtedness under the Amended Credit Agreement under certain circumstances. During the three months ended March 31, 2021, a prepayment of principal of $9.1 million was made.

The obligations of AgroFresh Inc., a wholly-owned subsidiary of the Company and the borrower under the Amended Credit Facility, are initially guaranteed by the Company and the Company’s wholly-owned subsidiary, AF Solutions Holdings LLC (together with AgroFresh Inc. and the Company, the “Loan Parties”) and may in the future be guaranteed by certain other domestic subsidiaries of the Company. The obligations of the Loan Parties under the Amended Credit Agreement and other loan documents are secured, subject to customary permitted liens and other agreed upon exceptions, by a perfected security interest in all tangible and intangible assets of the Loan Parties, except for certain excluded assets, and equity interests of certain foreign subsidiaries of the Loan Parties held by the Loan Parties (subject to certain exclusions and limitations).

At ~~March 31,~~June 30, 2022, there was ~~$261.8~~$261.1 million outstanding under the Amended Term Loan and no balance outstanding under the Amended Revolving Loan. At ~~March 31,~~June 30, 2022, the Company evaluated the amount recorded under the Amended Term Loan and determined that the fair value was approximately ~~$260.5~~$244.2 million. The fair value of the debt is based on quoted inactive market prices and is therefore classified as Level 2 within the valuation hierarchy.

On March 23, 2020, AgroFresh Fruit Protection entered into a €1.0 million loan agreement with Banco Santander, S.A., which provides funding through March 2023 at a 1.5% interest rate. In May 2020, AgroFresh Fruit Protection entered into a €0.3 million loan agreement with BBVA, which provides funding through May 2025 at a 2.2% interest rate. In July 2020, AgroFresh Fruit Protection entered into a €0.6 million loan agreement with Banco Santander, S.A., which provides funding through July 2025 at a 2.5% interest rate.


(in thousands)	(in thousands)	Amount	(in thousands)	Amount
2022 (remaining)	2022 (remaining)	$2,527	2022 (remaining)	$1,686
2023	2023	3,092	2023	3,075
2024	2024	257,242	2024	257,231
2025	2025	279	2025	265
Total	Total	$263,140	Total	$262,257

Most leases include an option to extend or renew the lease term. The exercise of the renewal option is at the Company's discretion. The operating lease liability includes lease payments related to options to extend or renew the lease term if the Company is reasonably certain of exercising those options. The Company, in determining the present value of lease payments, uses the Company’s incremental secured borrowing rate commensurate with the term of the underlying lease.


		Three Months Ended March 31,		Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	(in thousands)	2022	2021		(in thousands)	2022	2021		2022	2021
Operating Lease Cost	Operating Lease Cost				Operating Lease Cost
Operating leases	Operating leases	$502	$555		Operating leases	$495	$548		$997	$1,103
Short-term leases (1)	Short-term leases (1)	87	190		Short-term leases (1)	540	224		627	414
Total lease expense	Total lease expense	$589	$745		Total lease expense	$1,035	$772		$1,624	$1,517

Three Months Ended March 31,
2022 2021
Cash payments included in operating cash flows $487 $601
Right-of-use assets obtained in exchange for new lease $2,757 $123
Weighted average discount rate 7.69 % 8.77 %
Weighted average remaining lease term in years 6.3 years 4.5 years


	Six Months Ended June 30,
	2022		2021
Cash payments included in operating cash flows	$982		$1,145
Right-of-use assets obtained in exchange for new lease	$2,888		$242
Weighted average discount rate	7.71	%	8.79	%
Weighted average remaining lease term in years	6.1 years		4.4 years


(in thousands)	(in thousands)	Lease Liability	(in thousands)	Lease Liability
Remainder of 2022	Remainder of 2022	$1,515	Remainder of 2022	$981
2023	2023	1,748	2023	1,736
2024	2024	1,507	2024	1,498
2025	2025	1,326	2025	1,301
2026	2026	1,226	2026	1,195
Thereafter	Thereafter	2,879	Thereafter	2,730
Total undiscounted lease payments	Total undiscounted lease payments	10,201	Total undiscounted lease payments	9,441
Less: present value adjustment	Less: present value adjustment	2,092	Less: present value adjustment	1,881
Operating lease liability	Operating lease liability	$8,109	Operating lease liability	$7,560

The Company’s other noncurrent liabilities at ~~March 31,~~June 30, 2022 and December 31, 2021 consisted of the following:


(in thousands)	(in thousands)	March 31, 2022	December 31, 2021	(in thousands)	June 30, 2022	December 31, 2021
Lease liability	Lease liability	$6,709	$4,790	Lease liability	$6,202	$4,790
Other (1)	Other (1)	1,409	1,466	Other (1)	1,351	1,466
Total other noncurrent liabilities	Total other noncurrent liabilities	$8,118	$6,256	Total other noncurrent liabilities	$7,553	$6,256

Severance expense was ~~$0.1~~$0.8 million and ~~$0.02~~$1.5 million for the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively, and $0.8 million and $1.6 million for the six months ended June 30, 2022 and 2021, respectively. These amounts, which do not include stock compensation expense, were recorded in selling, general and administrative expense in the unaudited condensed consolidated statements of operations. As of ~~March 31,~~June 30, 2022 and December 31, 2021, the Company had ~~$0.4~~$0.9 million and $1.3 million of severance liability, respectively.

On November 7, 2017, the Company entered into a definitive agreement to acquire a controlling-interest in AgroFresh Fruit Protection. The transaction was closed on December 1, 2017. At the effective date of the acquisition, the Company acquired 75% of the outstanding capital stock of AgroFresh Fruit Protection. In connection with the acquisition of AgroFresh Fruit Protection, the Company concurrently entered into option agreements ("Option Agreement") with the Seller related to the remaining 25% equity interest. The Option Agreement permits the residual interest to be "put" by the Seller to the Company, or to allow the Company to "call" the residual interest gradually over time as outlined in the agreement. The Seller's ownership of AgroFresh Fruit Protection represents a NCI to the Company, which is classified outside of stockholders' equity as the option of the Seller is redeemable. As of ~~March 31,~~June 30, 2022 the carrying amount of the NCI was ~~$7.7~~$7.4 million in the unaudited condensed consolidated balance sheet. Any changes in the redemption value of the NCI are included as an adjustment to Additional paid-in capital on the balance sheet.


(in thousands)	(in thousands)	March 31, 2022	December 31, 2021	(in thousands)	June 30, 2022	December 31, 2021
Beginning balance	Beginning balance	($7,787)	($8,446)	Beginning balance	($7,787)	($8,446)
Net loss attributable to redeemable non-controlling interest	Net loss attributable to redeemable non-controlling interest	82	2,258	Net loss attributable to redeemable non-controlling interest	434	2,258
Adjustment of NCI to redemption value	Adjustment of NCI to redemption value	—	(1,599)	Adjustment of NCI to redemption value	—	(1,599)
Ending balance	Ending balance	($7,705)	($7,787)	Ending balance	($7,353)	($7,787)

On June 13, 2020, the Company entered into an Investment Agreement (the “Investment Agreement”) with PSP, an affiliate of Paine Schwartz Partners, LLC, pursuant to which, subject to certain closing conditions, PSP agreed to purchase in a private placement an aggregate of $150,000,000 of convertible preferred equity of the Company. The transaction closed on July 27, 2020 (the "Closing Date"), and a total of 150,000 shares of the Company’s newly-designated Series B-1 Convertible Preferred Stock, par value $0.0001 per share (the “Series B-1 Preferred Stock”), were purchased in such transaction (the “Private Placement”). On September 22, 2020, following the approval of the transactions contemplated by the Investment Agreement by the necessary regulatory body, the Company issued to PSP, for no additional consideration, a total of 150,000 shares of the Company’s newly-designated Series B-2 Convertible Preferred Stock, par value $0.0001 per share (the “Series B-2 Preferred Stock”). On September 25, 2020 (the "Exchange Date"), PSP elected to exchange the shares of the Company’s Series B-1 Convertible Preferred Stock and Series B-2 Preferred Stock held by it for a total of 150,000 shares of the Company’s newly-designated Series B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”). Accordingly, effective as of the Exchange Date, the Company issued 150,000 shares of Series B Convertible Preferred Stock, par value $0.0001 per share, to PSP and all of the shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock held by PSP were cancelled. No shares of Series B-1 Preferred Stock or Series B-2 Preferred Stock were outstanding as of ~~March 31,~~June 30, 2022.

The Series B Preferred Stock ranks senior to the shares of the Company’s common stock with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. The Series B Preferred Stock has a liquidation preference of $1,000 per share (the “Stated Value”). Holders of the Series B Preferred Stock are entitled to a cumulative dividend at a rate of 16% per annum, of which 50% was payable in cash and 50% was payable in kind until the first anniversary of the Closing Date, after which 50% is payable in cash, 37.5% is payable in kind, and the remaining 12.5% is payable in cash or in kind, at the Company’s option, subject in each case to adjustment under certain circumstances. Dividends on the Series B Preferred Stock are cumulative and payable quarterly in arrears. All dividends that are paid in kind will accrete to, and increase, the Stated Value. The applicable dividend rate is subject to increase by 2% per annum during any period that the Company is in breach of certain provisions of the Certificate of Designation of the Series B Preferred

Associated with the Series B Preferred Stock, the Company paid dividends of ~~$2.4~~$3.3 million in kind and ~~$4.0~~$3.3 million in cash during the three months ended ~~March 31,~~June 30, 2022, and $5.7 million in kind and $7.3 million in cash during the six months ended June 30, 2022. The Company paid dividends of ~~$3.0~~$3.3 million in kind and ~~$3.0~~$3.1 million in cash three months ended June 30, 2021, and $6.3 million in kind and $6.1 million in cash during the ~~three~~six months ended ~~March 31,~~June 30, 2021 associated with the Series B Preferred Stock. As of ~~March 31,~~June 30, 2022 and December 31, 2021, the Company had no accrued dividends.

The Series B Preferred Stock is convertible into Common Stock at the election of the holder at any time at an initial conversion price of $5.00 (“Conversion Price”). The Conversion Price is subject to customary adjustments, including for stock splits and other reorganizations affecting the Common Stock and pursuant to certain anti-dilution provisions for below market issuances. As of ~~March 31,~~June 30, 2022 and December 31, 2021, the maximum number of shares of common stock that could be issued upon conversion of the outstanding shares of Series B Preferred Stock was ~~32.7~~33.3 million and 32.2 million shares, respectively.


		Series B Convertible Preferred Stock				Series B Convertible Preferred Stock
(in thousands)	(in thousands)		Shares	Amount	(in thousands)		Shares	Amount
Balance at December 31, 2020	Balance at December 31, 2020		150	$143,728	Balance at December 31, 2020		150	$143,728
Redemption of shares	Redemption of shares		(5)	(5,330)	Redemption of shares		(5)	(5,330)
In kind dividend	In kind dividend		—	10,988	In kind dividend		—	10,988
Balance at December 31, 2021	Balance at December 31, 2021		145	149,386	Balance at December 31, 2021		145	149,386
In kind dividend	In kind dividend		—	2,414	In kind dividend		—	5,680
Balance at March 31, 2022			145	$151,800
Balance at June 30, 2022					Balance at June 30, 2022		145	$155,066

In connection with the consummation of the Investment Agreement, the Company and PSP entered into a Registration Rights Agreement (as amended, the “Registration Rights Agreement”), dated as of July 27, 2020. The Registration Rights Agreement provides that the Company will use its commercially reasonable efforts to prepare and file a shelf registration statement with the SEC within 30 days following a written request by PSP, and will use its commercially reasonable efforts to cause such shelf registration statement to be declared effective as promptly as is reasonably practicable after its filing to permit the public resale of registrable securities covered by the Registration Rights Agreement. The registrable securities generally include any shares of the Company’s common stock into which the Series B Preferred Stock is convertible, and any other securities issued or issuable with respect to any such shares of common stock by way of share split, share dividend, distribution, recapitalization, merger, exchange, replacement or similar event or otherwise.

In June 2019, the Company's shareholders approved the 2019 Employee Stock Purchase Plan (the "ESPP"), which was effective July 1, 2019. In August 2021, the number of shares reserved for issuance under the ESPP was increased to 1.25 million. The ESPP allows eligible employees to purchase shares of common stock at a discount of up to 15% through payroll deductions of their eligible compensation, subject to any plan limitations. The ESPP provides for six-month offering periods beginning January 1 and July 1 of each year, and each offering period consists of a six-month purchase period. On each purchase date, eligible employees may purchase the Company's common stock at a price per share equal to 85% of the lesser of (1) the fair market value of the common stock on the offering date or (2) the fair market value of the common stock on the purchase date. As of ~~March 31,~~June 30, 2022, ~~468,384~~564,233 shares had been issued under the ESPP.

Stock compensation expense for equity-classified and liability-classified awards was ~~$1.0~~$1.3 million and ~~$0.9~~$0.3 million for the three months ended ~~March 31,~~June 30, 2022 and 2021, respectively. Stock compensation expense for equity-classified and liability-classified awards was $2.3 million and $1.2 million for the six months ended June 30, 2022 and 2021, respectively. Stock compensation expense is recognized in cost of goods sold, selling, general and administrative expenses and research and development expenses. At ~~March 31,~~June 30, 2022, there was ~~$5.0~~$8.7 million of unrecognized compensation cost relating to outstanding unvested equity instruments expected to be recognized over the weighted average period of ~~1.8~~2.1 years.

During the three months ended June 30, 2022, the Company granted the following share-based awards to members of management and employees. These awards will be settled in shares of the Company's common stock and are equity-classified. The grant date fair value of the time-based awards will be recognized on a straight-line basis over the vesting period. The grant date fair value of the performance-based awards will be recognized on a straight-line basis over the vesting period based on the probability of achieving the performance condition. The performance-based restricted stock units each have a performance period that ends on December 31, 2024.

During the three months ended June 30, 2022, the Company also granted the following share-based awards to members of management employed in certain countries outside of the United States. These awards will be settled in cash and are liability-classified. Therefore, the fair value of these liability-classified awards will be re-measured on each balance sheet date. The performance-based phantom shares each have a performance period that ends on December 31, 2024.

~~The Company computes (loss) earnings~~Basic loss per share ~~("EPS") using the two-class method. The two-class method~~ is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. The outstanding shares of Series B Preferred Stock are participating securities because holders have non-forfeitable dividend rights and participate in undistributed earnings with common stock.

For the calculation of diluted EPS, net income for basic EPS is adjusted by the effect of dilutive securities. Diluted EPS attributable to common stockholders is computed by dividing the resulting net income for basic EPS adjusted by the effect of dilutive preferred stock by the weighted-average number of shares adjustedoutstanding for the effect of dilutive shares. The Company also applied the if-converted method to calculate dilution on the Series B Preferred Stock, which resulted in 31.0 million additional shares. This calculation was anti-dilutive.

Three Months Ended March 31,
(in thousands, except per share data) 2022 2021
Basic (loss) earnings per share:
Numerator Net (loss) income attributable to common stockholders ($9,523) $2,418
Less: Net income allocable to participating preferred stock — 914
Net (loss) income allocable to common stockholders (9,523) 1,504
Denominator Weighted average number of common stock outstanding 51,736 51,031
Basic (loss) earnings per share: ($0.18) $0.03
Diluted (loss) earnings per share:
Numerator Net (loss) income allocable to common stockholder ($9,523) $1,504
Denominator Weighted average number of shares
Common stock outstanding 51,736 51,031
Dilutive effect of restricted stock and restricted stock units — 1,265
Weighted number of shares used for diluted (loss) earnings per share 51,736 52,296
Diluted (loss) earnings per share ($0.18) $0.03


	Three Months Ended June 30,		Six Months Ended June 30,
(in thousands)	2022	2021	2022	2021
Basic weighted-average number of shares of common stock outstanding	52,089	51,348	51,913	51,191
Effect of dilutive options, restricted stock and restricted stock units	—	—	—	—
Diluted weighted-average number of shares of common stock outstanding	52,089	51,348	51,913	51,191


		Three Months Ended March 31,		Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	(in thousands)	2022	2021		(in thousands)	2022	2021		2022	2021
Convertible preferred stock	Convertible preferred stock	32,186	—		Convertible preferred stock	32,670	30,591		32,430	30,810
Stock-based compensation awards(1):	Stock-based compensation awards(1):				Stock-based compensation awards(1):
Stock options	Stock options	1,507	800		Stock options	1,508	899		1,507	849
Restricted stock awards and restricted stock units	Restricted stock awards and restricted stock units	3,668	22		Restricted stock awards and restricted stock units	5,417	2,655		4,726	2,161

The provision for income taxes consists of provisions for federal, state and foreign income taxes. The effective tax rates for the periods ended ~~March 31,~~June 30, 2022 and ~~March 31,~~June 30, 2021, reflect the Company’s expected tax rate on reported income (loss) from continuing operations before income tax and tax adjustments. The Company operates in a global environment with significant operations in the U.S. and various other jurisdictions outside the U.S. Accordingly, the consolidated income tax rate is a composite rate reflecting the Company’s earnings and the applicable tax rates in the various jurisdictions where the Company operates.

The Company's U.S. operations have incurred cumulative taxable losses through ~~March 31,~~June 30, 2022. The Company’s U.S. net operating loss carry forwards and carry forwards of other tax attributes are subject to review and possible adjustment by the Internal Revenue Service and state tax authorities. The utilization of the tax attributes have become restricted because of certain cumulative changes in the ownership interest of significant shareholders over a three-year period in excess of 50%, as defined under Section 382 and Section 383 of the Internal Revenue Code of 1986, as amended, as well as similar state tax provisions. This limits the amount of the tax attributes that the Company can utilize annually to offset future taxable income or tax liabilities. The amount of the annual limitation, if any, was determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. Please refer to Note 3 - Related Party Transactions regarding the ownership change in the quarter ended September 30, 2020. The Company completed a Section 382 study and determined the ownership change gave rise to the restrictions that will limit the realizability of certain U.S. tax

The effective tax rate for the ~~three~~six months ended ~~March 31,~~June 30, 2022 differs from the U.S. statutory tax rate of 21%, primarily because of changes in valuation allowance positions related to certain foreign ~~exchange currency gains and losses~~jurisdictions, taxable foreign inclusions within the U.S., and certain ~~non-taxable~~non-deductible items. The Company's effective tax rate for the three and six months ended ~~March 31,~~June 30, 2022 was ~~4.9%~~14.3% and 13.0%, compared to the effective tax rate for the three and six months ended ~~March��31,~~June 30, 2021 of ~~18.2%~~(0.8)% and (27.6)%.

ASC 280 requires use of the management approach for segment reporting. The management approach is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. Through the nine months ended September 31, 2021, the Company had operated and managed our business as 2 reportable segments, AgroFresh Core and AgroFresh Fruit Protection (formerly Tecnidex). Due to changes in senior management, as well as the integration of AgroFresh Fruit Protection with the Company's Core business operational and reporting structure, during the fourth quarter of 2021, the Company determined that it has 1 reportable segment as of December 31, 2021. Since the Company

The Company is currently involved in various claims and legal actions that arise in the ordinary course of business. The Company has recorded reserves for loss contingencies based on the specific circumstances of each case. Such reserves are recorded when it is probable that a loss has been incurred as of the balance sheet date and can be reasonably estimated. Although the results of litigation and claims can never be predicted with certainty, the Company does not believe that the ultimate resolution of these actions will have a material adverse effect on the Company’s business, financial condition or results of operations.

On October 14, 2019, the Company was awarded a verdict of $31.1 million in damages, related to, among other things, trade secret misappropriation and willful patent infringement, in its litigation against Decco Post-Harvest, Inc. ("Decco") and Decco's parent company, UPL Limited. The award was subsequently reduced by $18 million in connection with post-verdict review by the Court. During the three months ended March 31, 2021, the lawsuit was settled, paid and is considered closed.

~~During~~The Company had no material other income for the three months ended ~~March 31,~~June 30, 2022 or June 30, 2021. During the six months ended June 30, 2022, the Company had other income of $0.5 million ~~which~~ related ~~primarily~~ to the receipt of data sharing income. ~~The~~During the six months ended June 30, 2021 the Company had other income of $14.4 million ~~during the three months ended March 31, 2021 related primarily~~due to the receipt of proceeds from the settlement of a litigation matter.

This MD&A contains the financial measures EBITDA and Adjusted EBITDA, which are not presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). These non-GAAP financial measures are being presented because management believes that they provide readers with additional insight into the Company’s operational performance relative to earlier periods and relative to its competitors and they are key measures used by the Company to evaluate its performance. The Company does not intend for these non-GAAP financial measures to be a substitute for any GAAP financial information. Readers of this MD&A should use these non-GAAP financial measures only in conjunction with the comparable GAAP financial measures. A reconciliation of EBITDA and Adjusted EBITDA to the most comparable GAAP measure is provided in this MD&A.

All statements other than statements of historical fact included in this Report including, without limitation, statements in this MD&A regarding the Company's financial position, business strategy and the plans and objectives of management for future operations, are forward looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to the Company or its management, identify forward looking statements. Such forward looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, management. Actual results and/or the timing of events could differ materially from those contemplated by these forward-looking statements due to a number of factors, including those discussed under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021 (the "2021 Form 10-K") as well as the update to those Risk Factors disclosed in Part II, Item 1A of this Report. Any forward-looking statements included in this Report are based only on information currently available to the Company and speak only as of the date on which such statements are made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. All subsequent written or oral forward-looking statements attributable to the Company or persons acting on behalf of the Company are qualified in their entirety by this paragraph.

AgroFresh is a global leader in delivering innovative food preservation and waste reduction solutions for fresh produce. The Company is empowering the food industry with a range of integrated solutions designed to help growers, packers and retailers improve produce freshness and quality while reducing waste. AgroFresh has key products registered in over 50 countries, and supports customers by protecting approximately 25,000 storage rooms globally. AgroFresh's solutions range from near-harvest with Harvista™ and LandSpring™ to its flagship post-harvest SmartFresh™ Quality System. Additional post-harvest freshness solutions include fungicides that can be applied to meet various customer operational requirements, in either a foggable (ActiMist™) or liquid (ActiSeal™) delivery form. To supplement our near- and post-harvest product solutions, our FreshCloud™ digital technology platform includes analytical, diagnostic and tracking services that provide a range of value-added capabilities to help customers optimize the quality of their produce. Beyond apples, SmartFresh technology can provide ready-to-eat freshness for other fruits and vegetables including avocados, bananas, melons, tomatoes, broccoli and mangos.

In December 2017, AgroFresh acquired a controlling interest in AgroFresh Fruit Protection (formerly known as Tecnidex). With this acquisition, AgroFresh expanded its industry-leading post-harvest presence into additional crops and increased its penetration of the produce market in southern Europe, Latin America and Africa. For over 35 years, AgroFresh Fruit Protection has been helping fruit and vegetable producers offer clean, safe and high-quality products to customers in 18 countries. AgroFresh Fruit Protection offers a portfolio of post-harvest fungicides, coatings and disinfectants, packinghouse equipment and associated consulting and after-sale services to improves the quality and value of customers’ fruit and vegetables while respecting the environment. AgroFresh Fruit Protection further diversified AgroFresh’s revenue by allowing the Company to provide solutions and service to the citrus industry.

AgroFresh’s flagship SmartFresh Quality System regulates the post-harvest ripening effects of ethylene, the naturally occurring plant hormone that triggers ripening in certain fruits and vegetables. SmartFresh degrades naturally, leaves no detectable residue and has been approved for use by many domestic and global regulatory organizations. Harvista extends the Company’s proprietary technology into the field, including treatment of cherries early in the growing season and near-harvest management of apples, pears and blueberries. FreshCloud™ is our digital technology services platform, which continues to expand. Launched in 2020, FreshCloud Quality Inspection is a proprietary cloud-based mobile quality management service that digitizes what was formerly a manual quality control process and captures, organizes and analyzes quality metrics in real time. LandSpring™ is an innovative 1-MCP technology targeted to transplanted vegetable seedlings. It is currently registered for use on tomatoes, peppers and 14 other crops in the US. It reduces transplant shock, resulting in less seedling mortality and faster crop establishment, which leads to a healthier crop and improved yields.

AgroFresh’s business is highly seasonal, driven by the timing of the apple and pear harvests in the northern and southern hemispheres. The first half of the year is when the southern hemisphere harvest occurs, and the second half of the year is when the northern hemisphere harvest occurs. Since the northern hemisphere harvest of apples and pears is typically larger, a significant portion of our sales and profits are historically generated in the second half of the year. In addition to this seasonality, factors such as weather patterns may impact the timing of the harvest within the two halves of the year.

In March 2020, the COVID-19 outbreak was declared a National Public Health Emergency which continues to spread throughout the world and has adversely impacted global activity and contributed to significant volatility in financial markets. The outbreak could have a continued material adverse impact on economic and market conditions and trigger a period of global economic slowdown. During the ~~three~~six months ended ~~March 31,~~June 30, 2022, the COVID-19 pandemic did not have a significant adverse impact on our results of operations. However, there were numerous obstacles presented and some localized financial impacts of the pandemic, including fluctuations in foreign currency exchange rates and customer demand and spending pattern changes. While the Company is following the requirements of governmental authorities and taking additional preventative and protective measures to ensure the safety of its workforce, including implementing remote working arrangements and varying procedures for essential workforce, we cannot be 100% certain that there will not be any incidents across our global operations that may cause service interruptions. The rapid development and fluidity of this situation precludes any prediction as to the ultimate impact of the coronavirus outbreak, although the Company operates in an industry that thus far has not been as severely impacted as others. Nevertheless, the outbreak presents some uncertainty and risk with respect to the Company and its performance and financial results.

The Company sells to customers in approximately 50 countries and derives its revenue by assisting growers and packers to optimize the value of their crops primarily in the near and post-harvest periods. The Company's products and services add value to customers by reducing food spoilage and extending the life of perishable fruits. The Food and Agriculture Organization of the United Nations has estimated that a growing global population will require a near doubling of food production in developing countries by 2050 to meet the expected demand of a worldwide population expected to reach 9 billion people.

The global produce market is a function of both the size and the yield of the crop harvested; variations in either will affect total production. Given the nature of the agricultural industry, weather patterns may impact total production and the Company's resulting commercial opportunities. The Company supports a diverse customer base whose end markets vary due to the type of fruit and quality of the product demanded in their respective markets. Such variation across end markets also affects demand for the Company’s services.

The Company’s offerings are priced based on the value they provide to the Company’s customers. From time to time, the Company adjusts the pricing of its offerings to address market trends. The ~~Company does~~Company's offerings are priced based on the value they provide to the Company's customers and based on market economic factors including, but not ~~typically price its products in relation~~limited to, ~~any underlying cost~~inflation, currency exchange and materials cost. The timing of ~~materials or services; therefore, its margins can fluctuate with changes in these costs. The Company’s~~ pricing and economic factors could cause margin fluctuation. In addition, the Company's pricing model may include rebate arrangements ~~with customers in exchange~~ for ~~mutually beneficial~~ long-term ~~relationships and growth.~~agreements and/or significant volume achievements.

AgroFresh offers the Company’s commercially available products, including SmartFresh and Harvista, primarily through a direct service model. Sales and sales support personnel maintain face-to-face relationships with customers year round. Technical sales and support personnel work with customers to provide value-added advisory services regarding the application of SmartFresh. The actual application of SmartFresh is performed by service providers that are typically third-party contractors. Harvista is applied through both ground and aerial application, which are administered by third-party service providers or made by our customers directly.

The Company’s operations are subject to seasonal variation due to the timing of the growing seasons around the world. For our core crops of apples and pears, southern hemisphere growers harvest from late January to early May, and northern hemisphere growers harvest from August through November. For citrus crops, there are seasonal variations in this business due to the northern hemisphere citrus harvest, which spans from October to March. Since the majority of the Company’s sales are in northern hemisphere countries, a proportionately greater share of its revenue is realized during the second half of the year. There are also variations in the seasonal demands from year to year depending on weather patterns and crop size. This seasonality and variations in seasonal demand could impact the ability to compare results between periods.

With a global customer base and geographic footprint, the Company generates revenue and incurs costs in a number of different currencies, with the Euro comprising the most significant non-U.S. currency. Fluctuations in the value of these currencies relative to the U.S. dollar can increase or decrease the Company’s overall revenue and profitability as stated in U.S. dollars, which is the Company’s reporting currency. In certain instances, if sales in a given geography have been adversely impacted on a long-term basis due to foreign currency depreciation, the Company has been able to adjust its pricing so as to mitigate the impact on profitability.

Critical accounting policies are those accounting policies that can have a significant impact on the presentation of our financial condition and results of operations and that require the use of complex and subjective estimates based upon management’s judgment. Because of the uncertainty inherent in such estimates, actual results may differ materially from these estimates. There have been no material changes to our critical accounting policies and estimates previously disclosed in the 2021 Form 10-K. For a description of our critical accounting policies and estimates as well as a listing of our significant accounting policies, see “Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Use of Estimates” and “Note 2 - Basis of Presentation and Summary of Significant Accounting Policies” in the 2021 Form 10-K.


		Three Months Ended March 31,		Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	(in thousands)	2022	2021		(in thousands)	2022	2021		2022	2021
Net sales	Net sales	$39,889	$38,992		Net sales	$25,752	$21,924		$65,641	$60,916
Cost of sales (excluding amortization, shown separately below)	Cost of sales (excluding amortization, shown separately below)	11,923	10,314		Cost of sales (excluding amortization, shown separately below)	9,292	7,104		21,215	17,418
Gross profit	Gross profit	27,966	28,678		Gross profit	16,460	14,820		44,426	43,498
Research and development expenses	Research and development expenses	3,051	3,298		Research and development expenses	2,884	3,496		5,935	6,794
Selling, general and administrative expenses	Selling, general and administrative expenses	11,892	13,551		Selling, general and administrative expenses	14,334	13,620		26,226	27,171
Amortization of intangibles	Amortization of intangibles	10,718	10,763		Amortization of intangibles	10,708	10,499		21,426	21,262

Operating income		2,305	1,066
Other income		505	14,398
Operating loss					Operating loss	(11,466)	(12,795)		(9,161)	(11,729)
Other income (expense)					Other income (expense)	9	(46)		514	14,352

(Loss) gain on foreign currency exchange	(Loss) gain on foreign currency exchange	(1,196)	433		(Loss) gain on foreign currency exchange	(4,878)	921		(6,074)	1,354
Interest expense, net	Interest expense, net	(4,947)	(5,890)		Interest expense, net	(5,092)	(5,216)		(10,039)	(11,106)
(Loss) income before income taxes		(3,333)	10,007
Loss before income taxes					Loss before income taxes	(21,427)	(17,136)		(24,760)	(7,129)
Income taxes (benefit) expense	Income taxes (benefit) expense	(164)	1,823		Income taxes (benefit) expense	(3,058)	144		(3,222)	1,967
Net (loss) income including non-controlling interest		(3,169)	8,184
Net loss including non-controlling interest					Net loss including non-controlling interest	(18,369)	(17,280)		(21,538)	(9,096)
Less: Net loss attributable to non-controlling interest	Less: Net loss attributable to non-controlling interest	(82)	(239)		Less: Net loss attributable to non-controlling interest	(353)	(20)		(435)	(259)
Net (loss) income attributable to AgroFresh Solutions, Inc.		(3,087)	8,423
Net loss attributable to AgroFresh Solutions, Inc.					Net loss attributable to AgroFresh Solutions, Inc.	(18,016)	(17,260)		(21,103)	(8,837)
Less: Dividends on convertible preferred stock	Less: Dividends on convertible preferred stock	6,436	6,005		Less: Dividends on convertible preferred stock	6,533	6,327		12,969	12,332
Net (loss) income attributable to AgroFresh Solutions, Inc. common stockholders		($9,523)	$2,418
Net loss attributable to AgroFresh Solutions, Inc. common stockholders					Net loss attributable to AgroFresh Solutions, Inc. common stockholders	($24,549)	($23,587)		($34,072)	($21,169)

Net sales were ~~$39.9~~$25.8 million for the three months ended ~~March 31,~~June 30, 2022, as compared to net sales of ~~$39.0~~$21.9 million for the three months ended ~~March 31,~~June 30, 2021, an increase of ~~2.3%~~17.5%. The impact of the change in foreign currency exchange rates compared to the ~~first~~second quarter of 2021 decreased revenue by ~~$1.2~~$1.4 million. Excluding this impact, revenue increased approximately ~~5.5%~~23.9%, primarily driven by leveraging a portfolio of diverse solutions. Each of the Company's diversification categories generated growth in the ~~first quarter. Growth within Fungicides & Disinfectants was driven~~second quarter, led by ~~market penetration~~Antimicrobials and ~~product~~Coatings expansion in ~~the Middle East.~~EMEA. The Other 1-MCP category was ~~supported~~driven by ~~Harvista, which experienced strong growth~~SmartFresh expansion in South Africa, ~~supported by an early harvest~~Chile, and ~~larger crop size. This was partially offset by~~Australia and strong demand for Ethylbloc in North America amid the recovering flower industry. SmartFresh for Apple ~~declines~~experienced growth in ~~the~~ Latin America ~~region due to~~despite unfavorable weather ~~events.~~events and benefited from harvest timing differences.

Cost of sales was ~~$11.9~~$9.3 million for the three months ended ~~March 31,~~June 30, 2022, as compared to ~~$10.3~~$7.1 million for the three months ended ~~March 31,~~June 30, 2021. Gross profit margin was ~~70.1%~~63.9% for the three months ended ~~March 31,~~June 30, 2022 versus ~~73.5%~~67.6% for the three months ended ~~March 31,~~June 30, 2021. The lower gross margin primarily reflects the Company’s strategic transition to a more diversified product portfolio, ~~as well as~~ higher ~~materials~~material costs associated with inflationary ~~pressures.~~pressures, partially offset by price increases.

Loss on foreign currency was $4.9 million for the three months ended June 30, 2022, as compared to a gain of $0.9 million for the three months ended June 30, 2021. During the second quarter of 2022, foreign currency losses were recognized related to U.S. dollar intercompany receivables from the euro, Argentinian peso and South African rand, which grew weaker relative to the U.S. dollar along with losses due to the impact of hyperinflationary accounting in Turkey.

Net sales were $65.6 million for the six months ended June 30, 2022, as compared to net sales of $60.9 million for the six months ended June 30, 2021, an increase of 7.8%. The impact of the change in foreign currency exchange rates compared to the first half of 2021 reduced revenue by $2.6 million. Excluding this impact, revenue increased approximately 12.1%, primarily driven by leveraging a portfolio of diverse solutions. Each of the Company's diversification categories generated growth in the first half, led by Antimicrobials and Coatings market penetration and expansion in EMEA. SmartFresh Diversification, Ethylbloc and Harvista all contributed to growth in the Other 1-MCP category. This was partially offset by SmartFresh for Apple declines in Latin America in the Southern Hemisphere season due to unfavorable weather events.

Cost of sales was $21.2 million for the six months ended June 30, 2022, as compared to $17.4 million for the six months ended June 30, 2021. Gross profit margin was 67.7% for the six months ended June 30, 2022 versus 71.4% for the six months ended June 30, 2021. The lower gross margin primarily reflects the Company’s strategic transition to a more diversified product portfolio, higher material costs associated with inflationary pressures, partially offset by price increases.

Selling, general and administrative expenses were ~~$0.3~~$26.2 million infor the ~~current year and $0.8~~six months ended June 30, 2022, compared to $27.2 million infor the ~~prior year~~six months ended June 30, 2021, a decrease of costs associated with non-recurring items that include M&A and litigation, along with severance. Excluding these items, selling general and administrative expenses decreased approximately 9.0% in the first quarter versus the prior year period,3.5%, driven primarily by the timing of expenses.

Loss on foreign currency was ~~$1.2~~$6.1 million for the ~~three~~six months ended ~~March 31,~~June 30, 2022, as compared to a gain of ~~$0.4~~$1.4 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021. During the first ~~quarter~~half of 2022, foreign currency losses were recognized related to U.S. dollar intercompany receivables from the euro and Argentinian peso, which grew weaker relative to the U.S. ~~dollar.~~dollar along with losses due to the impact of hyperinflationary accounting in Turkey.

Interest expense was ~~$4.9~~$10.0 million for the ~~three~~six months ended ~~March 31,~~June 30, 2022, as compared to ~~$5.9~~$11.1 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021. The decrease was primarily due to higher interest income on investments of ~~$0.3~~$0.5 million, lower debt amortization of $0.3 million and to lower interest of $0.2 million on the long-term debt due to a lower principal ~~balance of $0.2 million.~~balance.

Income tax benefit was ~~$0.2~~$3.2 million for the ~~three~~six months ended ~~March 31,~~June 30, 2022, compared to income tax expense of ~~$1.8~~$2.0 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021. For the ~~three~~six months ended ~~March 31,~~June 30, 2022, the ~~quarter’s~~ largest effective tax rate ~~modification is~~modifications are related to changes in valuation allowance positions related to certain foreign ~~exchange currency gains and losses~~jurisdictions, taxable foreign inclusions within the U.S. and certain ~~non-taxable~~non-deductible items.

The following tables set forth the non-GAAP financial measures of EBITDA, Adjusted EBITDA and non-GAAP constant currency net sales. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s performance (including for incentive bonuses and bank covenant reporting), are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods. These non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.


		Three Months Ended March 31,		Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	(in thousands)	2022	2021		(in thousands)	2022	2021		2022	2021
GAAP net (loss) income including non-controlling interest		($3,169)	$8,184
GAAP net loss including non-controlling interest					GAAP net loss including non-controlling interest	($18,369)	($17,280)		($21,538)	($9,096)
Depreciation and amortization	Depreciation and amortization	11,444	11,423		Depreciation and amortization	11,448	11,178		22,892	22,600
Interest expense (1)	Interest expense (1)	4,947	5,890		Interest expense (1)	5,092	5,216		10,039	11,106
Income taxes (benefit) expense	Income taxes (benefit) expense	(164)	1,823		Income taxes (benefit) expense	(3,058)	144		(3,222)	1,967
Non-GAAP EBITDA	Non-GAAP EBITDA	13,058	27,320		Non-GAAP EBITDA	(4,887)	(742)		8,171	26,577
Share-based compensation	Share-based compensation	988	891		Share-based compensation	1,327	280		2,315	1,171
Severance related costs (2)	Severance related costs (2)	73	—		Severance related costs (2)	771	1,587		844	1,587
Other non-recurring costs (3)	Other non-recurring costs (3)	186	766		Other non-recurring costs (3)	324	754		510	1,520
Loss (gain) on foreign currency exchange (4)	Loss (gain) on foreign currency exchange (4)	1,196	(433)		Loss (gain) on foreign currency exchange (4)	4,878	(921)		6,074	(1,354)

Other income (5)	Other income (5)	(515)	—		Other income (5)	—			(515)	—
Litigation settlement	Litigation settlement	—	(14,392)		Litigation settlement	—			—	(14,392)
Total Adjustments	Total Adjustments	1,928	(13,168)		Total Adjustments	7,300	1,700		9,228	(11,468)
Non-GAAP Adjusted EBITDA	Non-GAAP Adjusted EBITDA	$14,986	$14,152		Non-GAAP Adjusted EBITDA	$2,413	$958		$17,399	$15,109


		Three Months Ended March 31,		Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	(in thousands)	2022	2021		(in thousands)	2022	2021		2022	2021
GAAP net sales	GAAP net sales	$39,889	$38,992		GAAP net sales	$25,752	$21,924		$65,641	$60,916
Impact from changes in foreign currency exchange rates	Impact from changes in foreign currency exchange rates	1,231	—		Impact from changes in foreign currency exchange rates	1,417	—		2,648	—
Non-GAAP constant currency net sales (1)	Non-GAAP constant currency net sales (1)	$41,120	$38,992		Non-GAAP constant currency net sales (1)	$27,169	$21,924		$68,289	$60,916

Cash Flows


		Three Months Ended March 31,			Six Months Ended June 30,
(in thousands)	(in thousands)	2022	2021	(in thousands)	2022	2021
Net cash provided by operating activities	Net cash provided by operating activities	$2,487	$23,326	Net cash provided by operating activities	$4,321	$30,876
Net cash used in investing activities	Net cash used in investing activities	($596)	($430)	Net cash used in investing activities	($1,672)	($1,304)
Net cash used in financing activities	Net cash used in financing activities	($4,846)	($18,236)	Net cash used in financing activities	($8,774)	($21,961)

Cash provided by operating activities was ~~$2.5~~$4.3 million for the ~~three~~six months ended ~~March 31,~~June 30, 2022, as compared to cash provided by operating activities of ~~$23.3~~$30.9 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021. In 2022, net income before non-cash depreciation and amortization was ~~$8.3~~$1.4 million. Other non-cash charges included stock-based compensation of ~~$0.9~~$2.2 million ~~$0.5~~and $1.0 million of deferred financing costs ~~and~~offset by a ~~$1.0~~$3.7 million decrease in net deferred taxes. Additionally, the change in net operating assets was ~~$6.4~~$3.3 million in 2022. For the ~~three~~six months ended ~~March 31,~~June 30, 2021, net income before non-cash depreciation and amortization was ~~$19.6~~$13.5 million. Other non-cash charges included stock-based compensation of ~~$0.8~~$1.1 million, ~~$0.8~~$1.3 million of deferred financing costs and a ~~$0.9~~$2.0 million increase in net deferred taxes. Additionally, the change in net operating assets was ~~$0.9~~$12.7 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021.

Cash used in financing activities was ~~$4.8~~$8.8 million for the ~~three~~six months ended ~~March 31,~~June 30, 2022, as compared to ~~$18.2~~$22.0 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021. Cash used in financing activities in 2022 was for the payment of dividends of ~~$4.0~~$7.3 million and the repayment of debt in the amount of ~~$0.8~~$1.6 million. Cash used in financing activities in 2021 was for the repayment of debt in the amount of ~~$9.9~~$10.7 million, redemption of preferred stock of $5.3 million and payment of dividends of ~~$3.0~~$6.1 million.

The Amended Credit Agreement provides for a $25.0 million revolving credit facility (the “Amended Revolving Loan”) which matures on June 30, 2024, and a $275.0 million term credit facility (the “Amended Term Loan” and, together with the Amended Revolving Loan, the “Amended Credit Facility”), which matures on December 31, 2024. The Amended Credit Facility includes a $5.0 million swingline commitment and a $10.0 million letter of credit sub-limit. Loans under the Amended Term Loan bear interest at a rate equal to, at the Company’s option, either the Adjusted Eurodollar Rate for the interest period in effect for such borrowing plus an Applicable Rate of 6.25% per annum, or the Alternate Base Rate plus an Applicable Rate of 5.25% per annum. Loans under the Amended Revolving Loan bear interest at a rate equal to, at the Company’s option, the Adjusted Eurodollar Rate for the interest period in effect for such borrowing plus the Applicable Rate ranging from 6.25% to 6.0% per annum, based on certain ratios. The interest rate was 7.25% for each of the three and six months ended ~~March 31,~~June 30, 2022. The Company is also required to pay a commitment fee on the unused portion of the Amended Revolving Loan at a rate ranging from 0.5% to 0.375%, based on certain ratios. The Company is required to make mandatory prepayments of outstanding indebtedness under the Amended Credit Agreement under certain circumstances. During the three months ended March 31, 2021, a prepayment of principal of $9.1 million was made.

At ~~March 31,~~June 30, 2022, there was ~~$261.8~~$261.1 million outstanding under the Amended Term Loan and no balance outstanding under the Amended Revolving Loan. Due to the prepayment, an additional $0.3 million of deferred financing costs were expensed based on the portion of debt paid. At ~~March 31,~~June 30, 2022, the Company evaluated the amount recorded under the Amended Term Loan and determined that the fair value was approximately ~~$260.5~~$244.2 million. The fair value of the debt is based on quoted inactive market prices and is therefore classified as Level 2 within the valuation hierarchy.

On June 13, 2020, the Company entered into an Investment Agreement (the “Investment Agreement”) with PSP AGFS Holdings, L.P. ("PSP"), an affiliate of Paine Schwartz Partners, LLC, pursuant to which, subject to certain closing conditions, PSP agreed to purchase in a private placement an aggregate of $150,000,000 of convertible preferred equity of the Company. The transaction closed on July 27, 2020 (the "Closing Date") and a total of 150,000 shares of the Company’s newly-designated Series B-1 Convertible Preferred Stock, par value $0.0001 per share (the “Series B-1 Preferred Stock”) were purchased in such transaction (the “Private Placement”). On September 22, 2020, following the approval of the transactions contemplated by the Investment Agreement by the necessary regulatory body, the Company issued to PSP, for no additional consideration, a total of 150,000 shares of the Company’s newly-designated Series B-2 Convertible Preferred Stock, par value $0.0001 per share (the “Series B-2 Preferred Stock”). On September 25, 2020 (the "Exchange Date"), PSP elected to exchange the shares of the Company’s Series B-1 Convertible Preferred Stock and Series B-2 Preferred Stock held by it for a total of 150,000 shares of the Company’s newly-designated Series B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”). Accordingly, effective as of the Exchange Date, the Company issued 150,000 shares of Series B Convertible Preferred Stock, par value $0.0001 per share, to PSP and all of the shares of Series B-1 Preferred Stock and Series B-2 Preferred Stock held by PSP were cancelled. No shares of Series B-1 Preferred Stock or Series B-2 Preferred Stock are outstanding as of ~~March 31,~~June 30, 2022.

The Series B Preferred Stock ranks senior to the shares of the Company’s common stock with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. The Series B Preferred Stock has a liquidation preference of $1,000 per share (the “Stated Value”). Holders of the Series B Preferred Stock are entitled to a cumulative dividend at a rate of 16% per annum, of which 50% was payable in cash and 50% was payable in kind until the first anniversary of Closing Date, after which 50% is payable in cash, 37.5% is payable in kind, and the remaining 12.5% is payable in cash or in kind, at the Company’s option, subject in each case to adjustment under certain circumstances. Dividends on the Series B Preferred Stock are cumulative and payable quarterly in arrears. All dividends that are paid in kind will accrete to, and increase, the Stated Value. The applicable dividend rate is subject to increase by 2% per annum during any period that the Company is in breach of certain provisions of the Certificate of Designation of the Series B Preferred Stock. The Series B Preferred Stock has been classified as temporary equity as it may be contingently redeemable in the event of a change of control, which is outside of the Company's control.

Associated with the Series B Preferred Stock, the Company paid dividends of ~~$2.4~~$3.3 million in kind and ~~$4.0~~$3.3 million in cash during the three months ended ~~March 31,~~June 30, 2022 and $5.7 million in kind and $7.3 million in cash during the six months ended June 30, 2022. The Company paid dividends of ~~$3.0~~$3.3 million in kind and ~~$3.0~~$3.1 million in cash during the three ~~and three~~ months ended ~~March 31,~~June 30, 2021, and $6.3 million in kind and $6.1 million in cash during the six months ended June 30, 2021 associated with the Series B Preferred Stock. As of ~~March 31,~~June 30, 2022 and December 31, 2021, the Company had no accrued dividends.

The Series B Preferred Stock is convertible into Common Stock at the election of the holder at any time at an initial conversion price of $5.00 (the “Conversion Price”). The Conversion Price is subject to customary adjustments, including for stock splits and other reorganizations affecting the Common Stock and pursuant to certain anti-dilution provisions for below market issuances. As of ~~March 31,~~June 30, 2022 and December 31, 2021, the maximum number of shares of common stock that could be issued upon conversion of the outstanding shares of Series B Convertible Preferred Stock was approximately ~~32.7~~33.3 million and 32.2 million shares, respectively.

The Company maintains disclosure controls and procedures within the meaning of Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act. The Company's disclosure controls are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms. The Company's disclosure controls are also designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our Disclosure Controls, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily applied its judgment in evaluating and implementing possible controls and procedures.

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of published financial statements in accordance with generally accepted accounting principles.

Management assessed the effectiveness of our internal control over financial reporting as of ~~March 31,~~June 30, 2022. In making this assessment, management used the criteria in Internal Control-Integrated Framework (2013) set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on our assessment using those criteria, management concluded that our internal control over financial reporting as of ~~March 31,~~June 30, 2022 was effective.

Ownership of our securities involves a high degree of risk. Holders of our securities should carefully consider, in addition to the historical financial statements and related notes and other information set forth in this Report, the risk factors discussed in Part I - Item 1A - Risk Factors included in our 2021 Form 10-K, all of which could materially affect our business or future results. We are not currently aware of any material changes to the risk factors disclosed in our 2021 Form 10-K. If any of the risks or uncertainties described in any of such risk factors actually occur, our business, financial condition and operating results could be adversely affected in a material way. This could cause the trading prices of our securities to decline, perhaps significantly, and you may lose part or all of your investment.


Exhibit No.		Description
3.1	(1)	Second Amended and Restated Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on July 31, 2015.
3.2	(4)	Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation.
3.3	(1)	Series A Certificate of Designation.
3.4	(6)	Certificate of Designation of Series B Convertible Preferred Stock.
3.5	(2)	Amended and Restated Bylaws.
3.6	(3)	Amendment to the Amended and Restated Bylaws of AgroFresh Solutions, Inc., effective as of September 3, 2015.
3.7	(5)	Amendment to the Amended and Restated Bylaws of AgroFresh Solutions, Inc., effective as of November 2, 2017.
4.1	(1)	Specimen Common Stock Certificate.
4.2	(1)	Specimen Warrant Certificate.
31.1	*	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.
31.2	*	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Act of 1934, as amended.
32.1	*	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	*	XBRL Instance Document
101.SCH	*	XBRL Taxonomy Extension Schema Document
101.CAL	*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	*	XBRL Taxonomy Extension Presentation Linkbase Document


(1)						Incorporated by reference to an exhibit to the Current Report on Form 8-K of the Company filed with the Securities and Exchange Commission on August 6, 2015.
(2)						Incorporated by reference to Annex A to the Company’s definitive proxy statement (File No. 001-36197) filed with the Securities and Exchange Commission on July 16, 2015.
(3)						Incorporated by reference to an exhibit to the Current Report on Form 8-K of the Company filed with the Securities and Exchange Commission on September 10, 2015.
(4)						Incorporated by reference to an exhibit to the Current Report on Form 8-K of the Company filed with the Securities and Exchange Commission on June 7, 2017.
(5)						Incorporated by reference to an exhibit to the Quarterly Report on Form 10-Q of the Company filed with the Securities and Exchange Commission on November 9, 2017.
(6)						Incorporated by reference to an exhibit to the Current Report on Form 8-K of the Company filed with the Securities and Exchange Commission on September 28, 2020.


Delaware			46-4007249
(State or other jurisdiction of incorporation)			(IRS Employer Identification Number)


			Page
PART I - FINANCIAL INFORMATION
	Item 1. Condensed Consolidated Financial Statements
		Unaudited Condensed Consolidated Balance Sheets	3
		Unaudited Condensed Consolidated Statements of Operations	4
		Unaudited Condensed Consolidated Statements of Comprehensive Loss	5
		Unaudited Condensed Consolidated Statement of Stockholders' Equity	6
		Unaudited Condensed Consolidated Statement of Cash Flows	78
		Notes to Unaudited Condensed Consolidated Financial Statements	89
	Item 2. Management's Discussion and Analysis of Financial Condition and Result of Operations		2224
	Item 3. Quantitative and Qualitative Disclosures About Market Risk		3135
	Item 4. Controls and Procedures		3135
PART II - OTHER INFORMATION			3236
	Item 1. Legal Proceedings		3236
	Item 1A. Risk Factors		3236
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		3337
	Item 3. Defaults Upon Senior Securities		3337
	Item 4. Mine Safety and Disclosures		3337
	Item 5. Other Information		3337
	Item 6. Exhibits		3438
SIGNATURES			3539


(in thousands)			Number of shares
Time-based restricted stock units			1,246
Performance-based restricted stock units			1,081
Total			2,327


(in thousands)			Level 3
Liability-classified stock compensation (1)			$~~275~~164


(in thousands)			Level 3
Liability-classified stock compensation (1)			$241



(1)			North America includes the United States and Canada.
(2)			EMEA includes Europe, the Middle East and Africa.
(3)			Latin America includes Argentina, Brazil, Chile, Costa Rica, Colombia, Dominican Republic, Ecuador, Guatemala, Mexico, Peru and Uruguay.

(4)			Asia Pacific includes Australia, China, India, Japan, New Zealand, the Philippines, South Korea, Taiwan and Thailand.


(in thousands)	Balance at December 31, 2020	Additions	Deductions	Balance at December 31, 2021
Contract assets:
Unbilled revenue	$1,484	17,617	(18,306)	$795
Contract liabilities:
Deferred revenue	$1,474	4,123	(4,962)	$635


(in thousands)			Number of shares
Time-based phantom shares			32
Performance-based phantom shares			18
Total			50


		Three Months Ended March 31,
(in thousands, except per share data)		2022	2021
Basic (loss) earnings per share:
Numerator	Net (loss) income attributable to common stockholders	($9,523)	$2,418
	Less: Net income allocable to participating preferred stock	—	914
	Net (loss) income allocable to common stockholders	(9,523)	1,504

Denominator	Weighted average number of common stock outstanding	51,736	51,031

	Basic (loss) earnings per share:	($0.18)	$0.03

Diluted (loss) earnings per share:
Numerator	Net (loss) income allocable to common stockholder	($9,523)	$1,504

Denominator	Weighted average number of shares
	Common stock outstanding	51,736	51,031
	Dilutive effect of restricted stock and restricted stock units	—	1,265
	Weighted number of shares used for diluted (loss) earnings per share	51,736	52,296

	Diluted (loss) earnings per share	($0.18)	$0.03



Grant date fair value			$1.70
Risk-free interest rate			0.27%
Expected life (years)			2.71
Estimated volatility factor			65.8%
Expected dividends			None


(in thousands)			Liability-classified stock compensation
Balance, December 31, 2021			$241
Stock compensation activity			34 (77)

Balance, ~~March 31,~~June 30, 2022			$~~275~~164


			AgroFresh Solutions, Inc.
			Date:			~~May 11,~~August 9, 2022

			/s/ Clinton A. Lewis, Jr.
			By:			Clinton A. Lewis, Jr.
			Title:			Chief Executive Officer

			/s/ Graham Miao
			By:			Graham Miao
			Title:			Chief Financial Officer